Skip to main content

Table 3 Moderating effect of omega-3 PUFAs on the association of TSE and current asthma

From: Effect of polyunsaturated fatty acids intake on the occurrence of current asthma among children and adolescents exposed to tobacco smoke: NHANES 2007–2018

Variables

Crude model*

Model 3

Model 4

AOR (95% CI)

P

AOR (95% CI)

P

AOR (95% CI)

P

TSE

1.22 (0.92–1.63)

0.172

1.12 (0.84–1.48)

0.441

0.91 (0.66–1.26)

0.577

Omega-3 PUFAs

0.71 (0.54–0.94)

0.018

0.74 (0.55–0.98)

0.038

0.63 (0.46–0.87)

0.005

TSE * Omega-3 PUFAs

1.51 (1.03–2.20)

0.034

1.51 (1.04–2.21)

0.032

1.71 (1.14–2.58)

0.010

  1. AOR adjusted odds ratio, CI confidence interval, Ref reference, PUFAs polyunsaturated fatty acids, TSE tobacco smoke exposure
  2. Crude Model*: only adjusted serum cotinine, omega-3 and serum cotinine*omega-3
  3. Model 3: adjusted serum cotinine, omega-3 PUFAs, serum cotinine*omega-3 PUFAs, age, gender and race
  4. Model 4: adjusted serum cotinine, omega-3 PUFAs, serum cotinine*omega-3 PUFAs, age, gender, race, sedentary time, overweight, relative asthma and hay fever